Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00330-017-4907-8
PubMed Identifier: 28656463
Publication URI: http://europepmc.org/abstract/MED/28656463
Type: Journal Article/Review
Parent Publication: European Radiology
Issue: 12
ISSN: 0938-7994